Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Regenerative chemical turns muscle cells into stem cells

23.12.2003


A group of researchers from The Scripps Research Institute has identified a small synthetic molecule that can induce a cell to undergo dedifferentiation - to move backwards developmentally from its current state to form its own precursor cell.


This compound, named reversine, causes cells which are normally programmed to form muscles to undergo reverse differentiation - retreat along their differentiation pathway and turn into precursor cells.

These precursor cells are multipotent; that is, they have the potential to become different cell types. Thus, reversine represents a potentially useful tool for generating unlimited supply of such precursors, which subsequently can be converted to other cell types, such as bone or cartilage.

"This [type of approach] has the potential to make stem cell research more practical," says Sheng Ding, Ph.D. "This will allow you to derive stem-like cells from your own mature cells, avoiding the technical and ethical issues associated with embryonic stem cells."



Ding, who is an assistant professor in the chemistry department at Scripps Research conducted the study--to be published in an upcoming issue of the Journal of the American Chemical Society--with Peter G. Schultz, Ph.D., who is a professor of chemistry and Scripps Family Chair of Scripps Research’s Skaggs Institute of Chemical Biology, and their colleagues.

Regenerative Medicine and Stem Cell Therapy

Stem cells have huge potential in medicine because they have the ability to differentiate into many different cell types--potentially providing doctors with the ability to produce cells that have been permanently lost by a patient.

For instance, the damage of neurodegenerative diseases like Parkinson’s, in which dopaminergic neurons in the brain are lost, may be ameliorated by regenerating neurons. Another example of a potential medical application is Type 1 diabetes, an autoimmune condition in which pancreatic islet cells are destroyed by the body’s immune system. Because stem cells have the power to differentiate into islet cells, stem cell therapy could potentially cure this chronic condition.

However bright this promise, many barriers must be overcome before stem cells can be used in medicine. Stem cell therapy would be most effective if you could use your own stem cells, since using one’s own cells would avoid potential complications from immune rejection of foreign cells. However, in general it has proven very difficult to isolate and propagate stem cells from adults. Embryonic stem cells (ESCs) offer an alternative, but face both practical and ethical hurdles associated with the source of cells as well as methods for controlling the differentiation of ESCs. A third approach is to use one’s own specialized cells and dedifferentiate them.

Normally, cells develop along a pathway of increasing specialization. Muscles, for instance, develop after embryonic stem cells develop into "mesenchymal" progenitor cells, which then develop into "myogenic" cells. These muscle cells fuse and form the fibrous bundles we know as muscles.

In humans and other mammals, these developmental events are irreversible, and in this sense, cell development resembles a family tree. One wouldn’t expect a muscle cell to develop into a progenitor cell any more than one would expect a woman to give birth to her own mother.

However, such phenomena do happen in nature from time to time.

Some amphibians have the ability to regenerate body parts that are severed by using dedifferentiation. When the unlucky amphibian loses a limb or its tail, the cells at the site of the wound will undergo dedifferentiation and form progenitor cells, which will then multiply and redifferentiate into specialized cells as they form an identical replacement to the missing limb or tail. In humans, the liver is unique in its regenerative capacity, possibly also involving dedifferentiation mechanism.

The Scripps Research scientists hope to find ways of mimicking this natural regeneration by finding chemicals that will allow them to develop efficient dedifferentiation processes whereby healthy, abundant, and easily accessible adult cells could be used to generate stem-like precursor cells, from which they could make different types of functional cells for repair of damaged tissues. Reversine is one of the first steps in this process.

However, tissue regeneration is years away at best, and at the moment, Schultz and Ding are still working on understanding the exact biochemical mechanism whereby reversine causes the muscle cells to dedifferentiate into their progenitors, as well as attempting to improve the efficiency of the process. "This [type of research] may ultimately facilitate development of small molecule therapeutics for stimulating the body’s own regeneration," says Ding. "They are the future regenerative medicine."


The article, "Dedifferentiation of Lineage-Committed Cells by a Small Molecule" is authored by Shuibing Chen, Qisheng Zhang, Xu Wu, Peter G. Schultz, and Sheng Ding and is available to online subscribers of the Journal of the American Chemical Society at: http://pubs.acs.org/cgi-bin/asap.cgi/jacsat/asap/html/ja037390k.html. The article will also be published in an upcoming issue of JACS.

This work was supported by The Skaggs Institute for Research and the Novartis Research Foundation.

Jason Bardi | EurekAlert!
Further information:
http://pubs.acs.org/cgi-bin/asap.cgi/jacsat/asap/html/ja037390k.html
http://www.scripps.edu/

More articles from Life Sciences:

nachricht Chains of nanogold – forged with atomic precision
23.09.2016 | Suomen Akatemia (Academy of Finland)

nachricht Self-assembled nanostructures hit their target
23.09.2016 | King Abdullah University of Science and Technology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

Im Focus: Complex hardmetal tools out of the 3D printer

For the first time, Fraunhofer IKTS shows additively manufactured hardmetal tools at WorldPM 2016 in Hamburg. Mechanical, chemical as well as a high heat resistance and extreme hardness are required from tools that are used in mechanical and automotive engineering or in plastics and building materials industry. Researchers at the Fraunhofer Institute for Ceramic Technologies and Systems IKTS in Dresden managed the production of complex hardmetal tools via 3D printing in a quality that are in no way inferior to conventionally produced high-performance tools.

Fraunhofer IKTS counts decades of proven expertise in the development of hardmetals. To date, reliable cutting, drilling, pressing and stamping tools made of...

Im Focus: Launch of New Industry Working Group for Process Control in Laser Material Processing

At AKL’16, the International Laser Technology Congress held in May this year, interest in the topic of process control was greater than expected. Appropriately, the event was also used to launch the Industry Working Group for Process Control in Laser Material Processing. The group provides a forum for representatives from industry and research to initiate pre-competitive projects and discuss issues such as standards, potential cost savings and feasibility.

In the age of industry 4.0, laser technology is firmly established within manufacturing. A wide variety of laser techniques – from USP ablation and additive...

Im Focus: New laser joining technologies at ‘K 2016’ trade fair

Every three years, the plastics industry gathers at K, the international trade fair for plastics and rubber in Düsseldorf. The Fraunhofer Institute for Laser Technology ILT will also be attending again and presenting many innovative technologies, such as for joining plastics and metals using ultrashort pulse lasers. From October 19 to 26, you can find the Fraunhofer ILT at the joint Fraunhofer booth SC01 in Hall 7.

K is the world’s largest trade fair for the plastics and rubber industry. As in previous years, the organizers are expecting 3,000 exhibitors and more than...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Experts from industry and academia discuss the future mobile telecommunications standard 5G

23.09.2016 | Event News

ICPE in Graz for the seventh time

20.09.2016 | Event News

Using mathematical models to understand our brain

16.09.2016 | Event News

 
Latest News

Chains of nanogold – forged with atomic precision

23.09.2016 | Life Sciences

New leukemia treatment offers hope

23.09.2016 | Health and Medicine

Self-assembled nanostructures hit their target

23.09.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>